NON-CERULOPLASMIN BOUND COPPER LEVEL MONITORING
The present invention relates to the treatment and/or monitoring of subjects suffering from, or susceptible to, Wilson's Disease, and involves measuring the serum non-ceruloplasmin (NCC) level in a subject and determining whether the serum NCC level is within a specified range. Treatment regime...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to the treatment and/or monitoring of subjects suffering from, or susceptible to, Wilson's Disease, and involves measuring the serum non-ceruloplasmin (NCC) level in a subject and determining whether the serum NCC level is within a specified range. Treatment regimes can be adjusted if appropriate to control the subject's serum NCC level to be within the desired range. |
---|